8403 related articles for article (PubMed ID: 2369092)
1. Compared cytotoxicity effects of five anticancer drugs on human (HBL) and mouse (B16) melanoma cells in vitro.
Arnould R; Dubois J; Abikhalil F; Libert A; Ghanem G; Atassi G; Hanocq M; Lejeune FJ
Anticancer Res; 1990; 10(3):789-93. PubMed ID: 2369092
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two cytotoxicity assays--tetrazolium derivative reduction (MTT) and tritiated thymidine uptake--on three malignant mouse cell lines using chemotherapeutic agents and investigational drugs.
Arnould R; Dubois J; Abikhalil F; Libert A; Ghanem G; Atassi G; Hanocq M; Lejeune FJ
Anticancer Res; 1990; 10(1):145-54. PubMed ID: 2334120
[TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxicity of hexamethylmelamine (HMM) and its derivatives.
Dubois J; Arnould R; Abikhalil F; Hanocq M; Atassi G; Ghanem G; Libert A; Lejeune FJ
Anticancer Res; 1990; 10(3):827-32. PubMed ID: 2114821
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic activity of azelaic acid against human melanoma primary cultures and established cell lines.
Zaffaroni N; Villa R; Silvestro L; Sanfilippo O; Silvestrini R
Anticancer Res; 1990; 10(6):1599-602. PubMed ID: 2285231
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative action of isatine-beta-thiocarbohydrazone and N-ethylisatine-beta-thiocarbohydrazone on human PBMC and on two neoplastic cell lines.
Juranić Z; Anastasova F; Juranić I; Stanojković T; Radulović S; Vuletić N
J Exp Clin Cancer Res; 1999 Sep; 18(3):317-24. PubMed ID: 10606176
[TBL] [Abstract][Full Text] [Related]
6. Characterization of B16 melanoma cells resistant to the CC-1065 analogue U-71,184.
Moy BC; Petzold GL; Badiner GJ; Kelly RC; Aristoff PA; Adams EG; Li LH; Bhuyan BK
Cancer Res; 1990 Apr; 50(8):2485-92. PubMed ID: 2317831
[TBL] [Abstract][Full Text] [Related]
7. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
[TBL] [Abstract][Full Text] [Related]
8. Drug sensitivity of heat-resistant mouse B16 melanoma variants.
Kroll DJ; Borgert CJ; Wiedmann TW; Rowe TC
Radiat Res; 1990 Oct; 124(1):15-21. PubMed ID: 2236492
[TBL] [Abstract][Full Text] [Related]
9. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
[TBL] [Abstract][Full Text] [Related]
10. Correlation of in vitro cytotoxicity with preclinical in vivo antitumor activity.
Rose WC; Schurig JE; Meeker JB
Anticancer Res; 1988; 8(3):355-67. PubMed ID: 3389740
[TBL] [Abstract][Full Text] [Related]
11. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
[TBL] [Abstract][Full Text] [Related]
12. DNA damage induced by a new 2-chloroethyl nitrosourea on malignant melanoma cells.
Godeneche D; Rapp M; Thierry A; Laval F; Madelmont JC; Chollet P; Veyre A
Cancer Res; 1990 Sep; 50(18):5898-903. PubMed ID: 2393861
[TBL] [Abstract][Full Text] [Related]
13. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the pharmacological antitumor effects of S 12363, a new vinca alkaloid.
Atassi G; Berlion M; el Oche Y; Bizzari JP
Anticancer Res; 1991; 11(2):975-80. PubMed ID: 2064354
[TBL] [Abstract][Full Text] [Related]
15. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo.
Arandjelovic SS; Bjelogrlic KS; Malesevic NN; Tesic LjZ; Radulovic SS
J BUON; 2009; 14(2):271-9. PubMed ID: 19650178
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic/antiproliferative effects of new [1,2,4]triazolo[4,3-c] quinazolines in tumor cell lines HeLa and B16.
Jantová S; Letasiová S; Ovádeková R; Múcková M
Neoplasma; 2006; 53(4):291-300. PubMed ID: 16830055
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic activity of quassinoids from Eurycoma longifolia.
Miyake K; Li F; Tezuka Y; Awale S; Kadota S
Nat Prod Commun; 2010 Jul; 5(7):1009-12. PubMed ID: 20734929
[TBL] [Abstract][Full Text] [Related]
19. Anticancer drug sensitivity profiles of new and established melanoma cell lines.
Marshall ES; Holdaway KM; Shaw JH; Finlay GJ; Matthews JH; Baguley BC
Oncol Res; 1993; 5(8):301-9. PubMed ID: 8012062
[TBL] [Abstract][Full Text] [Related]
20. [Tamoxifen increases cytotoxic effects of fotemustine. Experimental results on cell lines of human melanoma].
Fischel JL; Barbé V; Berlion M; Formento P; Berrile J; Bizzari JP; Milano G
Bull Cancer; 1994 Jul; 81(7):599-604. PubMed ID: 7742602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
